Literature DB >> 4899083

[Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].

A Loubatières, M M Mariani, G Ribes, H de Malbosc, R Alric, J Chapal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4899083

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  3 in total

1.  Extrapancreatic effect of glibenclamide: stimulation of duodenal insulin-releasing activity (DIRA) in man.

Authors:  A Zermatten; W Heptner; B Delaloye; R Séchaud; J P Felber
Journal:  Diabetologia       Date:  1977-04       Impact factor: 10.122

2.  Immunohistological demonstration of insulin in islets of langerhans after stimulation of insulin secretion by glucose, sulphonylureas and insulin antibodies.

Authors:  P A Bürkle; G Hemm; V Huber; K Federlin
Journal:  Diabetologia       Date:  1971-12       Impact factor: 10.122

3.  [Evaluation of the prolonged treatment of patients with the adult type of diabetes with glibenclamide (HB 419)].

Authors:  C R Aiello; D Turner; L Schwarzstein; R E Adrián; E A De Turner; N J Aparicio
Journal:  Acta Diabetol Lat       Date:  1971 Sep-Oct
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.